Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's Disease
It is difficult to differentiate between Parkinson's disease and multiple system atrophy parkinsonian subtype (MSA-P) because of the overlap of their signs and symptoms. Enormous efforts have been made to develop positron emission tomography (PET) imaging to differentiate these diseases. This s...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-04-01
|
| Series: | Frontiers in Aging Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2021.648531/full |
| _version_ | 1818640628511145984 |
|---|---|
| author | Wen-biao Xian Wen-biao Xian Xin-chong Shi Gan-hua Luo Chang Yi Xiang-song Zhang Zhong Pei Zhong Pei |
| author_facet | Wen-biao Xian Wen-biao Xian Xin-chong Shi Gan-hua Luo Chang Yi Xiang-song Zhang Zhong Pei Zhong Pei |
| author_sort | Wen-biao Xian |
| collection | DOAJ |
| description | It is difficult to differentiate between Parkinson's disease and multiple system atrophy parkinsonian subtype (MSA-P) because of the overlap of their signs and symptoms. Enormous efforts have been made to develop positron emission tomography (PET) imaging to differentiate these diseases. This study aimed to investigate the co-registration analysis of 18F-fluorodopa and 18F-flurodeoxyglucose PET images to visualize the difference between Parkinson's disease and MSA-P. We enrolled 29 Parkinson's disease patients, 28 MSA-P patients, and 10 healthy controls, who underwent both 18F-fluorodopa and 18F-flurodeoxyglucose PET scans. Patients with Parkinson's disease and MSA-P exhibited reduced bilateral striatal 18F-fluorodopa uptake (p < 0.05, vs. healthy controls). Both regional specific uptake ratio analysis and statistical parametric mapping analysis of 18F-flurodeoxyglucose PET revealed hypometabolism in the bilateral putamen of MSA-P patients and hypermetabolism in the bilateral putamen of Parkinson's disease patients. There was a significant positive correlation between 18F-flurodeoxyglucose uptake and 18F-fluorodopa uptake in the contralateral posterior putamen of MSA-P patients (rs = 0.558, p = 0.002). Both 18F-flurodeoxyglucose and 18F-fluorodopa PET images showed that the striatum was rabbit-shaped in the healthy control group segmentation analysis. A defective rabbit-shaped striatum was observed in the 18F-fluorodopa PET image of patients with Parkinson's disease and MSA-P. In the segmentation analysis of 18F-flurodeoxyglucose PET image, an intact rabbit-shaped striatum was observed in Parkinson's disease patients, whereas a defective rabbit-shaped striatum was observed in MSA-P patients. These findings suggest that there were significant differences in the co-registration analysis of 18F-flurodeoxyglucose and 18F-fluorodopa PET images, which could be used in the individual analysis to differentiate Parkinson's disease from MSA-P. |
| first_indexed | 2024-12-16T23:14:18Z |
| format | Article |
| id | doaj.art-0c6a7ff11e914e4e81a1ea50efec4255 |
| institution | Directory Open Access Journal |
| issn | 1663-4365 |
| language | English |
| last_indexed | 2024-12-16T23:14:18Z |
| publishDate | 2021-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Aging Neuroscience |
| spelling | doaj.art-0c6a7ff11e914e4e81a1ea50efec42552022-12-21T22:12:21ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652021-04-011310.3389/fnagi.2021.648531648531Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's DiseaseWen-biao Xian0Wen-biao Xian1Xin-chong Shi2Gan-hua Luo3Chang Yi4Xiang-song Zhang5Zhong Pei6Zhong Pei7Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, ChinaDepartment of Nuclear Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Nuclear Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Nuclear Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Nuclear Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, ChinaIt is difficult to differentiate between Parkinson's disease and multiple system atrophy parkinsonian subtype (MSA-P) because of the overlap of their signs and symptoms. Enormous efforts have been made to develop positron emission tomography (PET) imaging to differentiate these diseases. This study aimed to investigate the co-registration analysis of 18F-fluorodopa and 18F-flurodeoxyglucose PET images to visualize the difference between Parkinson's disease and MSA-P. We enrolled 29 Parkinson's disease patients, 28 MSA-P patients, and 10 healthy controls, who underwent both 18F-fluorodopa and 18F-flurodeoxyglucose PET scans. Patients with Parkinson's disease and MSA-P exhibited reduced bilateral striatal 18F-fluorodopa uptake (p < 0.05, vs. healthy controls). Both regional specific uptake ratio analysis and statistical parametric mapping analysis of 18F-flurodeoxyglucose PET revealed hypometabolism in the bilateral putamen of MSA-P patients and hypermetabolism in the bilateral putamen of Parkinson's disease patients. There was a significant positive correlation between 18F-flurodeoxyglucose uptake and 18F-fluorodopa uptake in the contralateral posterior putamen of MSA-P patients (rs = 0.558, p = 0.002). Both 18F-flurodeoxyglucose and 18F-fluorodopa PET images showed that the striatum was rabbit-shaped in the healthy control group segmentation analysis. A defective rabbit-shaped striatum was observed in the 18F-fluorodopa PET image of patients with Parkinson's disease and MSA-P. In the segmentation analysis of 18F-flurodeoxyglucose PET image, an intact rabbit-shaped striatum was observed in Parkinson's disease patients, whereas a defective rabbit-shaped striatum was observed in MSA-P patients. These findings suggest that there were significant differences in the co-registration analysis of 18F-flurodeoxyglucose and 18F-fluorodopa PET images, which could be used in the individual analysis to differentiate Parkinson's disease from MSA-P.https://www.frontiersin.org/articles/10.3389/fnagi.2021.648531/fullParkinson's diseasemutiple system atrophyPETFDGF-DOPA |
| spellingShingle | Wen-biao Xian Wen-biao Xian Xin-chong Shi Gan-hua Luo Chang Yi Xiang-song Zhang Zhong Pei Zhong Pei Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's Disease Frontiers in Aging Neuroscience Parkinson's disease mutiple system atrophy PET FDG F-DOPA |
| title | Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's Disease |
| title_full | Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's Disease |
| title_fullStr | Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's Disease |
| title_full_unstemmed | Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's Disease |
| title_short | Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's Disease |
| title_sort | co registration analysis of fluorodopa and fluorodeoxyglucose positron emission tomography for differentiating multiple system atrophy parkinsonism type from parkinson s disease |
| topic | Parkinson's disease mutiple system atrophy PET FDG F-DOPA |
| url | https://www.frontiersin.org/articles/10.3389/fnagi.2021.648531/full |
| work_keys_str_mv | AT wenbiaoxian coregistrationanalysisoffluorodopaandfluorodeoxyglucosepositronemissiontomographyfordifferentiatingmultiplesystematrophyparkinsonismtypefromparkinsonsdisease AT wenbiaoxian coregistrationanalysisoffluorodopaandfluorodeoxyglucosepositronemissiontomographyfordifferentiatingmultiplesystematrophyparkinsonismtypefromparkinsonsdisease AT xinchongshi coregistrationanalysisoffluorodopaandfluorodeoxyglucosepositronemissiontomographyfordifferentiatingmultiplesystematrophyparkinsonismtypefromparkinsonsdisease AT ganhualuo coregistrationanalysisoffluorodopaandfluorodeoxyglucosepositronemissiontomographyfordifferentiatingmultiplesystematrophyparkinsonismtypefromparkinsonsdisease AT changyi coregistrationanalysisoffluorodopaandfluorodeoxyglucosepositronemissiontomographyfordifferentiatingmultiplesystematrophyparkinsonismtypefromparkinsonsdisease AT xiangsongzhang coregistrationanalysisoffluorodopaandfluorodeoxyglucosepositronemissiontomographyfordifferentiatingmultiplesystematrophyparkinsonismtypefromparkinsonsdisease AT zhongpei coregistrationanalysisoffluorodopaandfluorodeoxyglucosepositronemissiontomographyfordifferentiatingmultiplesystematrophyparkinsonismtypefromparkinsonsdisease AT zhongpei coregistrationanalysisoffluorodopaandfluorodeoxyglucosepositronemissiontomographyfordifferentiatingmultiplesystematrophyparkinsonismtypefromparkinsonsdisease |